絞り込み

16645

広告

新型ウイルス肺炎 北朝鮮国営航空 外国人観光客は乗せない対応

中国で新型のコロナウイルスによるものとみられる肺炎への感染が広がっている問題を受けた北朝鮮の動きです。北朝鮮国営のコリョ(高麗)航空はNHKの取材に対し、北京か...

  1. 新型ウイルス肺炎 マカオでも感染者を初確...
  2. 調達情報 中小企業のための女性活躍推進事...
  3. 調達情報 民間人材サービスの活用検討事業...
  4. 書店水槽に「ぴろぴろの何か」 絶滅危惧ド...

ニュース一覧

Soluble SLAMF7 promotes the growth of myeloma cells via homophilic interaction with surface SLAMF7.

著者 Kikuchi J , Hori M , Iha H , Toyama-Sorimachi N , Hagiwara S , Kuroda Y , Koyama D , Izumi T , Yasui H , Suzuki A , Furukawa Y
Leukemia.2019 Jul 29 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (64view , 0users)

Full Text Sources

Miscellaneous

Research Materials

NBRP resources

SLAMF7 is expressed mainly on multiple myeloma (MM) cells and considered an ideal target for immunotherapeutic approaches. Indeed, elotuzumab, an anti-SLAMF7 antibody, is used for the treatment of MM in combination with immunomodulatory drugs. SLAMF7 is cleaved via unknown mechanisms and detected as a soluble form (sSLAMF7) exclusively in the serum of MM patients; however, little is known about the role of sSLAMF7 in MM biology. In this study, we found that sSLAMF7 enhanced the growth of MM cells via homophilic interaction with surface SLAMF7 and subsequent activation of the SHP-2 and ERK signaling pathways. Elotuzumab suppressed sSLAMF7-induced MM cell growth both in vitro and in vivo. Promoter analyses identified IKZF1 (Ikaros) as a pivotal transcriptional activator of the SLAMF7 gene. Pharmacological targeting of Ikaros by lenalidomide and its analog pomalidomide downregulated SLAMF7 expression and ameliorated the response of MM cells to sSLAMF7. Elotuzumab blocked the growth-promoting function of sSLAMF7 when combined with lenalidomide in a murine xenograft model. Neutralization of sSLAMF7 is a novel antimyeloma mechanism of elotuzumab, which is enhanced by immunomodulatory drugs via downregulation of surface SLAMF7 expression on MM cells. These findings may provide important information for the optimal use of elotuzumab in MM treatment.
PMID: 31358854 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード